Skip to main content
Atrás
Watch Compare

Larimar Therapeutics, Inc.

Calidad de datos: 83%
LRMR
Nasdaq Manufacturing Chemicals
$5.08
▼ $0.02 (-0.29%)
Cap. Mercado: 527.21 M
Precio
$5.08
Cap. Mercado
527.21 M
Rango del Día
$4.98 — $5.18
Rango de 52 Semanas
$1.72 — $6.42
Volumen
730,394
Apertura $5.09
Promedio 50D / 200D
$4.23
19.88% above
Promedio 50D / 200D
$3.85
31.78% above

Quick Summary

Puntos Clave

Negative free cash flow of -113.29 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-127.99%
Below sector avg (-51.02%)
ROIC-102.63%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio4.06
Interest CoverageN/A

Valoración

PE (TTM)
-3.18
Below sector avg (-1.98)
P/B Ratio3.79
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -3.2 -2.0
P/B 3.8 5.1
ROE % -128.0 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.01% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -165.67 M
ROE -127.99% ROA -98.22%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -113.29 M
ROIC -102.63% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.06
Interest Coverage N/A Asset Turnover N/A
Working Capital 138.11 M Tangible Book Value 139.04 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.18 Forward P/E N/A
P/B Ratio 3.79 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -21.49%
Market Cap 527.21 M Enterprise Value 437.07 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -1.09 OCF / Share -1.09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 68.38%
SBC-Adj. FCF -120.70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -165.67 M -80.60 M -36.95 M -35.36 M -50.64 M
EPS (Diluted) — -1.32 -0.84 -1.37 -2.95
Gross Profit — — — — —
Operating Income -172.50 M -90.89 M -41.76 M -36.53 M -50.47 M
EBITDA — — — — —
R&D Expenses 154.22 M 73.28 M 27.67 M 24.25 M 38.40 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 145.84 M 200.23 M 95.94 M 126.41 M 78.67 M
Total Liabilities 67.76 M 28.41 M 14.22 M 15.50 M 14.25 M
Shareholders' Equity 78.09 M 171.81 M 81.72 M 110.90 M 64.41 M
Total Debt — — — — —
Cash & Equivalents 85.41 M 33.22 M 26.75 M 26.83 M 70.10 M
Current Assets 142.02 M 195.30 M 90.18 M 120.74 M 72.20 M
Current Liabilities 64.80 M 24.36 M 9.51 M 10.71 M 8.85 M